observed that key oncogenic driving alteration (such as H3, IDH, and BRAF mutations) were conserved in primary and recurrent specimens, and that the primary tumor DNA methylation-based subgrouping is maintained at recurrence. The gene discussed is BRAF; the disease is neoplasm.